85 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Lacrimal Apparatus Diseases" (85 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
2 Recruiting Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
3 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Intervention: Drug: KPI-121
4 Recruiting Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Conditions: Blepharitis;   Dry Eye Syndrome
Interventions: Device: LipiFlow Pre-Treatment;   Device: LipiFlow Post-treatment
5 Recruiting The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Dietary Supplement: Omega-3 (Triglyceride form)
6 Recruiting Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Procedure: Lid debridgement scaling
7 Recruiting Exercise in Sjogren and Myositis
Conditions: Primary Sjogren´s Syndrome;   Myositis
Intervention: Other: Exercise training
8 Recruiting Primary Sjögren Syndrome
Condition: Primary Sjögren's Syndrome
Intervention: Other: skin biopsy
9 Recruiting Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Procedure: Sialoendoscopy;   Drug: saline;   Drug: hydrocortisone
10 Unknown  Diurnal Variation in Tear Osmolarity
Condition: Dry Eye Disease
Intervention:
11 Recruiting Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
Condition: Dry Eye
Interventions: Drug: PRO-148;   Drug: Systane
12 Recruiting Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Device: T2762;   Device: Vismed®
13 Recruiting Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Conditions: Primary Sjogren Syndrome;   Secondary Sjogren Syndrome;   Aqueous Deficient Dry Eye Disease;   Evaporative Dry Eye Disease
Interventions: Drug: Restasis;   Drug: Refresh Endura
14 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle
15 Not yet recruiting Dry Eye Assessment and Management Study
Condition: Dry Eye
Interventions: Drug: Omega-3 supplements;   Drug: Placebo
16 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Healthy Subjects;   Osteoarthritis;   Auto-immune Disease;   Lupus;   Systemic Sclerosis;   Sjögren Syndrome;   Spondylitis;   Crystal Rheumatisms
Intervention: Other: Comparison of Bregs levels
17 Recruiting Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Conditions: Primary Sjogren's Syndrome;   Secondary Sjogren's Syndrome;   Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention: Drug: Abatacept
18 Recruiting Agricultural Health Study Follow-up
Conditions: Rheumatoid Arthritis;   Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention:
19 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
20 Recruiting Multi-Colored Placido Disk Viability
Conditions: Dry Eye;   Sjogren's Disease;   Healthy
Intervention: Procedure: Multi-colored Placido disk imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years